Page 14 - புனே அடிப்படையிலானது சீரம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(Picture for representation) BENGALURU: The exclusion of Covishield, AstraZeneca’s Covid-19 vaccine manufactured by Pune-based Serum Institute of India, from the European Union’s Covid ‘Green Pass’ has left hundreds of Europe-bound students and working professionals confused and helpless. While AstraZeneca’s Vaxzervia is one of four vaccines recognised by the European Medicines Agency (EMA), the same vaccine manufactured in India and distributed under the name Covishield has not been approved. A majority of the more than 2,000 students and working professionals, who got themselves jabbed with Covishield at a special camp, are anxiously waiting and hoping that EMA will approve SII’s Covishield. Students who are planning to pursue their education abroad will have to travel soon since the academic year for many universities begins in August/September.

Astrazeneca covidAstrazeneca vaxzerviaSurabhi kumarEuropean medicines agencySerum institute of indiaEuropean union covid green pasWorld health organisationPune based serum instituteEuropean unionGreen pasசுராபி குமார்சீரம் நிறுவனம் ஆஃப் இந்தியாஉலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்புனே அடிப்படையிலானது சீரம் நிறுவனம்ஐரோப்பிய தொழிற்சங்கம்பச்சை பாஸ்